1. Home
  2. BSET vs INDP Comparison

BSET vs INDP Comparison

Compare BSET & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bassett Furniture Industries Incorporated

BSET

Bassett Furniture Industries Incorporated

HOLD

Current Price

$18.96

Market Cap

169.9M

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.26

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSET
INDP
Founded
1902
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.9M
171.9M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
BSET
INDP
Price
$18.96
$1.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.9K
175.7K
Earning Date
04-01-2026
05-11-2026
Dividend Yield
5.49%
N/A
EPS Growth
163.06
N/A
EPS
0.37
N/A
Revenue
$456,855,000.00
N/A
Revenue This Year
$1.72
N/A
Revenue Next Year
$3.78
N/A
P/E Ratio
$50.97
N/A
Revenue Growth
0.96
N/A
52 Week Low
$13.17
$0.92
52 Week High
$22.26
$8.57

Technical Indicators

Market Signals
Indicator
BSET
INDP
Relative Strength Index (RSI) 43.02 29.98
Support Level $18.78 $0.92
Resistance Level $20.81 $2.95
Average True Range (ATR) 0.66 0.14
MACD -0.19 0.01
Stochastic Oscillator 1.98 13.12

Price Performance

Historical Comparison
BSET
INDP

About BSET Bassett Furniture Industries Incorporated

Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: